Analysts Viewpoint
ALT’s short interest reaches 28.1 million shares on 2025-07-15
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Menu
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Altimmune Inc’s recently made public that its Director Sohn Catherine A. acquired Company’s shares for reported $5784.0 on Mar 17
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
In a filing, Altimmune Inc revealed its Director Sohn Catherine A. acquired Company’s shares for reported $5784.0 on Mar 17
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Altimmune Inc’s recently made public that its Director Sohn Catherine A. acquired Company’s shares for reported $5784.0 on Mar 17
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Altimmune Inc’s recently made public that its Director Sohn Catherine A. acquired Company’s shares for reported $5784.0 on Mar 17
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Altimmune Inc’s filing revealed that its Director Sohn Catherine A. acquired Company’s shares for reported $5784.0 on Mar 17 ’25.